Raymond Alexanian, MD, Oral History Interview, June 5, 2014

Title

Raymond Alexanian, MD, Oral History Interview, June 5, 2014

Files

Loading...

Media is loading
 

Description

Major Topics Covered:

  • Committees at MD Anderson: Research Committee, Surveillance Committee, Transfusion Task Force, Faculty Classification Committee;
  • The research and cultural environment of MD Anderson under Dr. R. Lee Clark;
  • Changes with growth of MD Anderson;
  • The impact of regulation on research and innovation

Publication Date

6-5-2014

Publisher

The Historical Resources Center, The Research Medical Library, The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Disciplines

History of Science, Technology, and Medicine | Oncology | Oral History

About the Interview

About the Interview Subject

Dr. Raymond Alexanian (b. 8 June 1932, Queens, New York) joined MD Anderson in 1964 as an Assistant Professor of Medicine and served as Section Chief of Myeloma for many years. He retired in 2013 and holds Emeritus status. Dr. Alexanian achieved a national reputation through his work on erythropoietin, then shifted his specialization to cancer and to myeloma. At MD Anderson he innovated combination therapies for the disease. In collaboration with Bart Barlogie, MD, PhD, he developed a treatment combining chemotherapy and stem cell transplantation. Most recently he has written on the difficulty of defining “cure” in myeloma. In 2001 he received the Waldenström Award for his work in myeloma research.

Raymond Alexanian, MD, Oral History Interview, June 5, 2014

Share

COinS